Injectrode Platform for Chronic Pain

About Neuronoff

Neuronoff is pioneering a novel approach to peripheral neuromodulation with its Injectrode platform, a minimally invasive, injectable electrode designed to replace repeat drug injections for chronic pain. The company aims to lower the barriers to neuromodulation by enabling device placement and removal in a typical 20-minute clinic visit, positioning it as an earlier treatment option rather than a last resort. With over 52 million US adults suffering from chronic pain and a clear clinical need for drug-free, practical therapies, Neuronoff's technology targets a significant market gap. The platform has demonstrated multi-site IPG compatibility, suggesting potential expansion beyond its initial pain indication.

Therapeutic Areas

Other Chronic Pain Drugs